12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

APPY1: Pivotal trial started

Venaxis began a U.S. pivotal trial to evaluate APPY1 in about 2,000 patients ages 2-20 years who present in the hospital emergency department with abdominal pain with suspicion of appendicitis and who have blood drawn as part...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >